Valneva SE
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
/ 
Frequently asked questions
To buy Valneva SE stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Valneva SE by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Valneva SE is VLA:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Valneva SE has its primary listing on Euronext Paris. You can trade Valneva SE with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Valneva SE is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Valneva SE as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Valneva SE.